155 related articles for article (PubMed ID: 18794615)
21. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.
Sullivan PS; Hanson DL; Teshale EH; Wotring LL; Brooks JT
AIDS; 2006 May; 20(8):1171-9. PubMed ID: 16691069
[TBL] [Abstract][Full Text] [Related]
22. Autoimmune diseases-related arthritis in HIV-infected patients in the era of highly active antiretroviral therapy.
Yang JJ; Tsai MS; Sun HY; Hsieh SM; Chen MY; Sheng WH; Chang SC
J Microbiol Immunol Infect; 2015 Apr; 48(2):130-6. PubMed ID: 24064287
[TBL] [Abstract][Full Text] [Related]
23. Cigarette smoking and mortality among HIV-infected individuals in Seattle, Washington (1996-2008).
Pines H; Koutsky L; Buskin S
AIDS Behav; 2011 Jan; 15(1):243-51. PubMed ID: 20390335
[TBL] [Abstract][Full Text] [Related]
24. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
[TBL] [Abstract][Full Text] [Related]
25. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
Moore RD; Keruly JC
Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
[TBL] [Abstract][Full Text] [Related]
26. Patients presenting with AIDS in the HAART era: a collaborative cohort analysis.
Mussini C; Manzardo C; Johnson M; Monforte Ad; Uberti-Foppa C; Antinori A; Gill MJ; Sighinolfi L; Borghi V; Lazzarin A; Miró JM; Sabin C;
AIDS; 2008 Nov; 22(18):2461-9. PubMed ID: 19005269
[TBL] [Abstract][Full Text] [Related]
27. Highly active anti-retroviral therapy (HAART)-induced maintenance of adaptive but not innate immune parameters is associated with protection from HIV-induced mortality.
Stebbing J; Bower M; Mandalia S; Nelson M; Gazzard B
Clin Exp Immunol; 2006 Aug; 145(2):271-6. PubMed ID: 16879246
[TBL] [Abstract][Full Text] [Related]
28. Impact of injecting drug use on response to highly active antiretroviral treatment in HIV-1-infected patients: a nationwide population-based cohort study.
Larsen MV; Omland LH; Gerstoft J; Røge BT; Larsen CS; Pedersen G; Obel N; Kronborg G
Scand J Infect Dis; 2010 Dec; 42(11-12):917-23. PubMed ID: 20840000
[TBL] [Abstract][Full Text] [Related]
29. [In-hospital mortality in HIV-infected patients: 10 years after the implementation of universal access to HAART in Mexico].
Martín-Onraet A; Piñeirua-Menéndez A; Perales-Martínez D; Ortega-Pérez R; Barrera-García A; Sierra-Madero J; Volkow-Fernández P
Salud Publica Mex; 2015; 57 Suppl 2():s163-70. PubMed ID: 26545132
[TBL] [Abstract][Full Text] [Related]
30. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
[TBL] [Abstract][Full Text] [Related]
31. Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area.
Martínez E; Milinkovic A; Buira E; de Lazzari E; León A; Larrousse M; Loncá M; Laguno M; Blanco JL; Mallolas J; García F; Miró JM; Gatell JM
HIV Med; 2007 May; 8(4):251-8. PubMed ID: 17461853
[TBL] [Abstract][Full Text] [Related]
32. Trends in perimortal conditions and mortality rates among HIV-infected patients.
Hooshyar D; Hanson DL; Wolfe M; Selik RM; Buskin SE; McNaghten AD
AIDS; 2007 Oct; 21(15):2093-100. PubMed ID: 17885300
[TBL] [Abstract][Full Text] [Related]
33. Sustained favourable HIV viral load response in South African patients during concomitant HAART and cancer therapy.
Musyoki AM; Msibi TL; Motswaledi MH; Selabe SG; Mphahlele MJ
J Med Virol; 2015 Feb; 87(2):192-8. PubMed ID: 25156795
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy.
Bisson GP; Gross R; Strom JB; Rollins C; Bellamy S; Weinstein R; Friedman H; Dickinson D; Frank I; Strom BL; Gaolathe T; Ndwapi N
AIDS; 2006 Aug; 20(12):1613-9. PubMed ID: 16868442
[TBL] [Abstract][Full Text] [Related]
35. Clinical and immunologic profile of AIDS-related lymphoma in the era of highly active antiretroviral therapy.
Barclay LR; Buskin SE; Kahle EM; Aboulafia DM
Clin Lymphoma Myeloma; 2007 Jan; 7(4):272-9. PubMed ID: 17324334
[TBL] [Abstract][Full Text] [Related]
36. Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion.
Smit C; Geskus R; Walker S; Sabin C; Coutinho R; Porter K; Prins M;
AIDS; 2006 Mar; 20(5):741-9. PubMed ID: 16514305
[TBL] [Abstract][Full Text] [Related]
37. Cause of death in HIV-infected patients in South Carolina (2005-2013).
Cima M; Parker RD; Ahmed Y; Cook S; Dykema S; Dukes K; Albrecht S; Weissman S
Int J STD AIDS; 2016 Jan; 27(1):25-32. PubMed ID: 25691444
[TBL] [Abstract][Full Text] [Related]
38. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.
Bouhnik AD; Préau M; Vincent E; Carrieri MP; Gallais H; Lepeu G; Gastaut JA; Moatti JP; Spire B;
Antivir Ther; 2005; 10(1):53-61. PubMed ID: 15751763
[TBL] [Abstract][Full Text] [Related]
39. Human immunodeficiency virus-associated primary lung cancer in the era of highly active antiretroviral therapy: a multi-institutional collaboration.
D'Jaen GA; Pantanowitz L; Bower M; Buskin S; Neil N; Greco EM; Cooley TP; Henry D; Stem J; Dezube BJ; Stebbing J; Aboulafia DM
Clin Lung Cancer; 2010 Nov; 11(6):396-404. PubMed ID: 21062730
[TBL] [Abstract][Full Text] [Related]
40. Impact of hepatitis B virus co-infection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: a nationwide cohort study.
Omland LH; Weis N; Skinhøj P; Laursen A; Christensen PB; Nielsen HI; Møller A; Engsig F; Sørensen HT; Obel N
HIV Med; 2008 May; 9(5):300-6. PubMed ID: 18400077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
